---
$id: https://graph.org.ai/products/commodity/51413213
$type: Product
source: UNSPSC
code: "51413213"
title: "Avanafil"
class: "51413200"
classTitle: "Vasodilator piperazines"
family: "51410000"
familyTitle: "Vasodilators"
segment: "51000000"
segmentTitle: "Pharmaceutical Products incl. Contraceptives and Vaccines"


---

# Avanafil

**UNSPSC Code**: 51413213
**Class**: [Vasodilator piperazines](Vasodilator piperazines.mdx)
**Family**: [Vasodilators](../Vasodilators.mdx)
**Segment**: [Pharmaceutical Products incl. Contraceptives and Vaccines](../../Pharmaceutical Products incl. Contraceptives and Vaccines.mdx)

This classification denotes a cgmp phosphodiesterase inhibitor with the molecular structure C23H26CLN7O3, a preparation that US FDA recognizes as an active ingredient or moiety under Unique Ingredient Identifier, DR5S136IVO chemically known as 5-pyrimidinecarboxamide, 4-(((3-chloro-4-methoxyphenyl)methyl)amino)-2-((2s)-2-(hydroxymethyl)-1-pyrrolidinyl)-n-(2-pyrimidinylmethyl)-, but more commonly known as avanafil, which bears U.S. NIH Compound Identifier 9869929. European Medicines Agency schedules Avanafil in its eXtended EudraVigilance Medicinal Product Dictionary or XEVMPD under Index SUB34916. The term AVANAFIL is an International Non-Proprietary Name or INN (see World Health Organization INN reference publication, volume 19, no. 3, 2005, list 54).

